Free reading from the same research desk that produces the VISURIAN books.
A plain-English guide to the study designs, evidence terms, and research concepts that help readers interpret peptide science without confusing hypotheses with established findings.
Examine what human observational, exercise-related, and intervention research has measured about MOTS-c, while separating endogenous findings from administered treatment evidence and animal or laboratory research.
Learn what FDA approval means for peptide drugs, why peptides are not one regulatory category, and how approval differs from research, compounding, FDA listings, and online sales.
Explore how growth hormone–releasing peptides and secretagogues work, what human studies have measured, and where evidence remains limited for meaningful health outcomes.
Examine what CJC-1295 and ipamorelin research has measured, how their endocrine mechanisms differ, and where human evidence remains limited for meaningful outcomes.
Learn how to read peptide evidence across laboratory, animal, observational, uncontrolled, and randomized human research without confusing mechanisms with demonstrated outcomes.
Learn how to evaluate peptide studies, from cell and animal models through randomized human research, while separating mechanisms, surrogate endpoints, and statistical signals from meaningful outcomes.
Understand what people mean by a peptide stack, how combinations are described, and why the term does not by itself establish a shared mechanism, safety profile, or clinical benefit.
Explore TB-500 research on tissue repair and recovery while separating proposed mechanisms and preclinical findings from what has actually been established in humans.
Compare what BPC-157 research has measured in humans and animals, separating preclinical repair signals from the limited evidence available in people.
Compare BPC-157 and TB-500 research on repair and recovery while separating molecule-specific findings, preclinical evidence, human data, and unanswered safety questions.
Compare GHK-Cu, BPC-157, and TB-500 research on repair and recovery while separating their proposed mechanisms, evidence strength, and unanswered safety questions.
Explore BPC-157 research on tissue repair, tendon and gastrointestinal findings, and the limits of translating mostly preclinical evidence to human outcomes.
Explore the GHK-Cu copper-peptide complex in skin and collagen research, separating proposed repair mechanisms, laboratory findings, and evidence in humans.
Appraise GHK-Cu research on extracellular-matrix collagen, wound repair, and human skin findings while distinguishing measured signals from demonstrated efficacy.
Explore NAD+ redox chemistry, ATP production, and compartment-specific metabolism while separating cellular mechanisms from evidence about human outcomes.
Explore MOTS-c’s mitochondrial origin, the proposed AMPK signaling pathway, and what human evidence does—and does not—show compared with laboratory research.
Understand NAD+ in redox chemistry and cellular energy, including its relationships with sirtuins and PARPs, while separating human evidence from preclinical findings without clinical hype.
Learn what MOTS-c is, what research has actually measured, and where evidence from cellular, animal, and human studies still leaves important questions unanswered.
Compare a cellular coenzyme with a mitochondrial-derived peptide: their biology, human and preclinical evidence, and what an ongoing MOTS-c trial can—and cannot—tell us.
A measured look at age-related NAD+ metabolism, tissue-specific findings, and why results from different studies and models should not be treated as one universal human decline.
I've read 40+ books in this category over the past two years. Most of them have the same problem — and it's not what you'd guess. Here's the pattern, and what an honest book in this space looks like instead.
An evidence-limited look at MOTS-c’s mitochondrial origin, the exercise-related research hypothesis, mouse findings, and uncertainty around human evidence.